Evidence map›Paper›PMID 39377378›Full record

ReviewCurrent medicinal chemistry2025

Quassinoids as Promising Anti-cancer Agents.

Tripti Mishra, Saima, Bimal Krishna Banik

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tripti MishraCentre of Innovative and Applied Bioprocessing (CIAB), Sector-81, Knowledge City, Mohali, Punjab, India.ORCID 0000-0003-1044-1603
SaimaSchool of Advanced Chemical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan, Himachal Pradesh, India.ORCID 0000-0003-2261-636X
Bimal Krishna BanikCollege of Sciences and Human Studies, Prince Mohammad Bin Fahd University, Al Khobar, 31952, Saudi Arabia.ORCID 0000-0002-7873-9062

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of current anticancer drugs is hampered by significant side effects and high costs. In the pursuit of safer, more effective, and affordable options, researchers have turned to nature as a valuable source of potential anticancer compounds. Quassinoids, a class of natural terpenoids, have garnered attention for their anticancer properties. This comprehensive review aims to shed light on natural quassinoids and their anticancer effects, offering valuable insights for researchers dedicated to the development of novel anticancer therapeutics.

Indexed as

Antineoplastic AgentsNeoplasmsQuassinsAnimalsCell ProliferationHumansAntineoplastic AgentsQuassinscancerchemotherapycytotoxicQuassinoidssignalling pathways.Simaroubaceae

Identifiers

PMID39377378

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.